​

Funding Round

Series E - Chimerix

Series E - Chimerix

Investment Firm

Overview

Chimerix is a biotechnology company developing therapeutics for antiviral diseases.

Announced Date

Aug 10, 2009

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

4

Investor Name
Participant InvestorAsset Management Company
Participant InvestorAlta Partners
Participant InvestorSanderling Ventures
Participant InvestorCanaan Partners

Round Details and Background

Chimerix raised $16100000 on 2009-08-10 in Series E

Chimerix is a biotechnology company developing therapeutics for antiviral diseases.

Company Funding History

14

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 23, 2007
Series D - Chimerix
6-23.1M
Feb 14, 2011
Series F - Chimerix
8-45.0M
Nov 04, 2004
Series C - Chimerix
3-11.0M
Aug 10, 2009
Series E - Chimerix
5-16.1M

Recent Activity

There is no recent news or activity for this profile.